Renalytix plc Equity Method Investments, Fair Value Disclosure
Renalytix plc (RENXF) had Equity Method Investments, Fair Value Disclosure of $0 as of 2022-06-30, per its 20-F filed 2022-10-31.
Discontinued › Notes › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:EquityMethodInvestmentsFairValueDisclosure · last filed 2022-10-31
- 2022-06-30: Equity Method Investments, Fair Value Disclosure $0.00.
- 2022-03-31: Equity Method Investments, Fair Value Disclosure $0.00.
- 2021-12-31: Equity Method Investments, Fair Value Disclosure $0.00.
- 2021-06-30: Equity Method Investments, Fair Value Disclosure $0.00.
| Period end | Equity Method Investments, Fair Value Disclosure |
|---|---|
| 2022-06-30 | $0.00 20-F · filed 2022-10-31 |
| 2022-03-31 | $0.00 6-K · filed 2022-06-30 |
| 2021-12-31 | $0.00 6-K/A · filed 2022-04-29 |
| 2021-06-30 | $0.00 20-F · filed 2022-10-31 |